Rescue Therapy for Lamivudine-resistant Chronic Hepatitis B: Adefovir Monotherapy, Adefovir Plus Lamivudine or Entecavir Combination Therapy
Minghao Ha(Wuhan No. 7 Hospital), Zhongming Huang(Pudong Medical Center), Lihui Shen(Pudong Medical Center), ChunHong Huang(Stanford University), Wenjuan Shen(Wuhan Polytechnic University), Guotong Zhang(Pudong Medical Center), Shu Diao(Pudong Medical Center), Liping Sun(Yangzhou University), Ming-Fang Lin(Pudong Medical Center), Huiyuan She(Pudong Medical Center), Jianqiu Wu(Jiangsu Cancer Hospital)
Cited by 21
Related Papers
Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China
|Journal of Hematology & Oncology|2017|256
Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment
|Frontiers in Immunology|2021|227
ZmLEA3, a Multifunctional Group 3 LEA Protein from Maize (Zea mays L.), is Involved in Biotic and Abiotic Stresses
|Plant and Cell Physiology|2013|216